Kyung Dong Pharmaceutical Co. Ltd (011040) — Net Asset Quality Index
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Net Asset Quality Index of 74.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩309.30 Billion minus total liabilities of ₩79.70 Billion yields net assets of ₩229.60 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Kyung Dong Pharmaceutical Co. Ltd (011040) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Kyung Dong Pharmaceutical Co. Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how Kyung Dong Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 74.2%, representing net assets of ₩229.60 Billion against total assets of ₩309.30 Billion KRW. Explore 011040 cash generation efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 011040 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.1% | ₩228.87 Billion | ₩321.90 Billion | ₩93.02 Billion | ▼ -1.6 pp |
| 2024 | 72.7% | ₩220.06 Billion | ₩302.87 Billion | ₩82.81 Billion | ▼ -5.3 pp |
| 2023 | 78.0% | ₩228.48 Billion | ₩292.97 Billion | ₩64.49 Billion | ▼ -4.9 pp |
| 2022 | 82.8% | ₩257.20 Billion | ₩310.48 Billion | ₩53.27 Billion | ▼ -6.1 pp |
| 2021 | 89.0% | ₩259.82 Billion | ₩291.97 Billion | ₩32.15 Billion | ▼ -1.0 pp |
| 2020 | 90.0% | ₩262.19 Billion | ₩291.39 Billion | ₩29.21 Billion | ▲ +11.1 pp |
| 2019 | 78.8% | ₩226.71 Billion | ₩287.59 Billion | ₩60.88 Billion | ▼ -3.3 pp |
| 2018 | 82.1% | ₩211.72 Billion | ₩257.79 Billion | ₩46.08 Billion | ▼ -5.8 pp |
| 2017 | 87.9% | ₩220.95 Billion | ₩251.43 Billion | ₩30.47 Billion | ▼ -0.1 pp |
| 2016 | 88.0% | ₩209.93 Billion | ₩238.49 Billion | ₩28.56 Billion | ▲ +0.1 pp |
| 2015 | 87.9% | ₩205.14 Billion | ₩233.41 Billion | ₩28.28 Billion | ▲ +4.2 pp |
| 2014 | 83.6% | ₩190.43 Billion | ₩227.68 Billion | ₩37.25 Billion | ▼ -0.7 pp |
| 2013 | 84.4% | ₩169.03 Billion | ₩200.39 Billion | ₩31.35 Billion | ▲ +3.1 pp |
| 2012 | 81.3% | ₩153.76 Billion | ₩189.23 Billion | ₩35.48 Billion | ▲ +0.2 pp |
| 2011 | 81.1% | ₩150.62 Billion | ₩185.72 Billion | ₩35.10 Billion | — |